Literature DB >> 9262185

Astroglial expression of hepatocyte growth factor and hepatocyte growth factor activator in human brain tissues.

T Yamada1, Y Yoshiyama, Y Tsuboi, T Shimomura.   

Abstract

Hepatocyte growth factor (HGF) is a potent mitogen for mature hepatocytes, and also has multifunctional effects on some other cells in various organs. A HGF activating protease, HGF activator (HGFA) has recently been identified as a key enzyme that regulates the activity of HGF in vivo. HGFA appears to be associated with the cell surface. We examined HGFA immunolabelling in the brains of neurologically normal and Alzheimer disease (AD) cases. Furthermore, we identified the expression of the mRNA for HGF and HGFA by in situ hybridization histochemistry. The HGFA antibody stained only astrocytes in the white matter in all the brain tissues. Expression of the mRNAs of HGF and HGFA was also seen in white matter astrocytes. These results suggest that, in human brain, secreted pro-HGF from astrocytes might be activated by HGFA on/or near the astrocytic cell surface.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9262185     DOI: 10.1016/s0006-8993(97)00504-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Hepatocyte growth factor acts as a mitogen and chemoattractant for postnatal subventricular zone-olfactory bulb neurogenesis.

Authors:  Tsu-Wei Wang; Huailin Zhang; Margaret R Gyetko; Jack M Parent
Journal:  Mol Cell Neurosci       Date:  2011-06-12       Impact factor: 4.314

2.  Hepatocyte growth factor is a mitogen for olfactory ensheathing cells.

Authors:  H Yan; X Nie; J D Kocsis
Journal:  J Neurosci Res       Date:  2001-11-15       Impact factor: 4.164

3.  Hepatocyte growth factor system in the mouse uterus: variation across the estrous cycle and regulation by 17-beta-estradiol and progesterone.

Authors:  Xuan Zhang
Journal:  Biol Reprod       Date:  2010-02-10       Impact factor: 4.285

4.  Failures in preclinical and clinical trials of c-Met inhibitors: evaluation of pathway activity as a promising selection criterion.

Authors:  Veronica S Hughes; Dietmar W Siemann
Journal:  Oncotarget       Date:  2019-01-04

5.  Reduced HGF/MET Signaling May Contribute to the Synaptic Pathology in an Alzheimer's Disease Mouse Model.

Authors:  Jing Wei; Xiaokuang Ma; Antoine Nehme; Yuehua Cui; Le Zhang; Shenfeng Qiu
Journal:  Front Aging Neurosci       Date:  2022-07-12       Impact factor: 5.702

6.  Systematic review of human post-mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimer's disease.

Authors:  Lucía Viejo; Ayush Noori; Emily Merrill; Sudeshna Das; Bradley T Hyman; Alberto Serrano-Pozo
Journal:  Neuropathol Appl Neurobiol       Date:  2021-08-17       Impact factor: 6.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.